Literature DB >> 8774330

Clinical implications of hypertrophic cardiomyopathy associated with mutations in the alpha-tropomyosin gene.

K Yamauchi-Takihara1, C Nakajima-Taniguchi, H Matsui, Y Fujio, K Kunisada, S Nagata, T Kishimoto.   

Abstract

OBJECTIVE: The disease-bearing genes for hypertrophic cardiomyopathy (HCM) in HCM families have been identified as the beta-myosin heavy chain, alpha-tropomyosin, and cardiac troponin T genes. Three HCM kindreds with three distinct point mutations in the alpha-tropomyosin gene had extensive clinical evaluations. DESIGN AND
RESULTS: Single-strand conformation polymorphism gel analysis of polymerase chain reaction amplified products was used to capture each of the nine exons from the alpha-tropomyosin gene to identify mutations in 60 familial HCM patients. Two missense mutations in exon 2 (Ala63Val and Lys70Thr) and one missense mutation in exon 5 (Asp175Asn) were found in three unrelated HCM kindreds. These kindreds were the subject of clinical, electrocardiographic and echocardiographic studies. The morphological appearance of HCM was similar in the three kindreds. All the patients had severe hypertrophy of the left ventricle with asymmetrical septal hypertrophy during the early stage of the disease, which gradually progressed to dilatation of the left ventricle. Moreover, these kindreds showed similar disease penetrance, age of onset, and incidence of premature sudden death. The disease in these kindreds was severe and resulted in frequent sudden deaths.
CONCLUSIONS: Among Japanese patients with familial HCM mutations in the alpha-tropomyosin gene are not as rare as reported, accounting for about 5% of all cases. These mutations are characterised by hypertrophy of the left ventricle which then progresses to dilatation and a high incidence of sudden or disease-related death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774330      PMCID: PMC484428          DOI: 10.1136/hrt.76.1.63

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

1.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

Review 2.  Structural aspects of troponin-tropomyosin regulation of skeletal muscle contraction.

Authors:  A S Zot; J D Potter
Journal:  Annu Rev Biophys Biophys Chem       Date:  1987

3.  A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.

Authors:  L Thierfelder; C MacRae; H Watkins; J Tomfohrde; M Williams; W McKenna; K Bohm; G Noeske; M Schlepper; A Bowcock
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Characterization of muscle and non muscle Xenopus laevis tropomyosin mRNAs transcribed from the same gene. Developmental and tissue-specific expression.

Authors:  S Hardy; M Y Fiszman; H B Osborne; P Thiebaud
Journal:  Eur J Biochem       Date:  1991-12-05

5.  Isolation and characterization of a cDNA that encodes mouse fibroblast tropomyosin isoform 2.

Authors:  K Takenaga; Y Nakamura; K Tokunaga; H Kageyama; S Sakiyama
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

6.  A novel deletion mutation in the beta-myosin heavy chain gene found in Japanese patients with hypertrophic cardiomyopathy.

Authors:  C Nakajima-Taniguchi; H Matsui; N Eguchi; S Nagata; T Kishimoto; K Yamauchi-Takihara
Journal:  J Mol Cell Cardiol       Date:  1995-12       Impact factor: 5.000

7.  Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

Authors:  B J Maron; J S Gottdiener; S E Epstein
Journal:  Am J Cardiol       Date:  1981-09       Impact factor: 2.778

8.  Alpha-tropomyosin gene organization. Alternative splicing of duplicated isotype-specific exons accounts for the production of smooth and striated muscle isoforms.

Authors:  N Ruiz-Opazo; B Nadal-Ginard
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

9.  Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11.

Authors:  L Carrier; C Hengstenberg; J S Beckmann; P Guicheney; C Dufour; J Bercovici; E Dausse; I Berebbi-Bertrand; C Wisnewsky; D Pulvenis
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

10.  Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy.

Authors:  S Nagata; Y Park; T Minamikawa; C Yutani; T Kamiya; T Nishimura; T Kozuka; H Sakakibara; Y Nimura
Journal:  Am Heart J       Date:  1985-06       Impact factor: 4.749

View more
  13 in total

1.  Primary prevention of sudden cardiac death in a low-risk child with familial hypertrophic cardiomyopathy: the role of cardiac magnetic resonance imaging.

Authors:  Hirokuni Yamazawa; Atsuhito Takeda; Kouta Takei; Takuo Furukawa
Journal:  Clin Res Cardiol       Date:  2013-10-30       Impact factor: 5.460

Review 2.  The genomics of cardiovascular disorders: therapeutic implications.

Authors:  P Ferrari; G Bianchi
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

3.  Investigating the effects of tropomyosin mutations on its flexibility and interactions with filamentous actin using molecular dynamics simulation.

Authors:  Wenjun Zheng; Sarah E Hitchcock-DeGregori; Bipasha Barua
Journal:  J Muscle Res Cell Motil       Date:  2016-07-04       Impact factor: 2.698

4.  Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.

Authors:  Ayako Chida; Kei Inai; Hiroki Sato; Eriko Shimada; Tsutomu Nishizawa; Mitsuyo Shimada; Michiko Furutani; Yoshiyuki Furutani; Yoichi Kawamura; Masaya Sugimoto; Jun Ishihara; Masako Fujiwara; Takashi Soga; Masatoshi Kawana; Shinya Fuji; Shigeru Tateno; Kenji Kuraishi; Shigetoyo Kogaki; Mitsuhiro Nishimura; Mamoru Ayusawa; Fukiko Ichida; Hirokuni Yamazawa; Rumiko Matsuoka; Shigeaki Nonoyama; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2016-11-24       Impact factor: 2.037

5.  Prevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy.

Authors:  R Thaman; J R Gimeno; R T Murphy; T Kubo; B Sachdev; J Mogensen; P M Elliott; W J McKenna
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

Review 6.  Alpha-tropomyosin mutations in inherited cardiomyopathies.

Authors:  Charles Redwood; Paul Robinson
Journal:  J Muscle Res Cell Motil       Date:  2013-09-05       Impact factor: 2.698

Review 7.  Thin filament mutations: developing an integrative approach to a complex disorder.

Authors:  Jil C Tardiff
Journal:  Circ Res       Date:  2011-03-18       Impact factor: 17.367

Review 8.  A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium.

Authors:  Fan Bai; Li Wang; Masataka Kawai
Journal:  J Muscle Res Cell Motil       Date:  2013-05-23       Impact factor: 2.698

9.  Defective regulation of contractile function in muscle fibres carrying an E41K beta-tropomyosin mutation.

Authors:  Julien Ochala; Meishan Li; Monica Ohlsson; Anders Oldfors; Lars Larsson
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

Review 10.  Familial cardiomyopathies: significant causes of heart failure.

Authors:  Kathy A Crispell
Journal:  Curr Cardiol Rep       Date:  2003-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.